- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07942038
Myocardial Fibrosis and Deformation Kinetics After the Ross Procedure Using Cardiac MRI
Myocardial Tissue Characterization and Deformation Kinetics Following the Ross Procedure: A Prospective Multiparametric CMR Study
The Ross procedure entails pulmonary autograft replacement of the aortic valve, primarily indicated in pediatric and young adult cohorts presenting with severe aortic valve disease. Despite postoperative preservation of left ventricular ejection fraction (LVEF) on resting transthoracic echocardiography, a subset of recipients exhibits blunted peak oxygen consumption (peak VO2), subclinical electromechanical dyssynchrony, and ventricular arrhythmias.
Chronic severe aortic valve pathology induces distinct myocardial remodeling patterns. Chronic pressure overload (aortic stenosis) triggers concentric cardiomyocyte hypertrophy and diffuse interstitial fibrosis. Chronic volume overload (aortic regurgitation) induces eccentric left ventricular dilatation and extracellular matrix degradation with collagen disarray. Following surgical hemodynamic unloading, left ventricular mass regresses; however, the extent of diffuse interstitial collagen matrix resorption versus pure cardiomyocyte cellular volume regression remains uncharacterized in this demographic.
This prospective longitudinal study employs multiparametric cardiovascular magnetic resonance (CMR) imaging to evaluate myocardial tissue characterization and deformation kinetics in young adults undergoing the Ross procedure. Participants will undergo contrast-enhanced CMR at baseline and at 12 months postoperatively. Quantitative endpoints include native T1 mapping, extracellular volume fraction (ECV), indexed extracellular volume (iECV), and three-dimensional (3D) feature-tracking strain (global longitudinal, circumferential, and radial strain). The primary objective is to correlate the resolution of diffuse microscopic fibrosis with subclinical mechanical recovery, comparing remodeling trajectories between pressure-overloaded and volume-overloaded phenotypes.
연구 개요
상태
정황
연구 유형
등록 (추정된)
참여기준
자격 기준
공부할 수 있는 나이
- 어린이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
The study population comprises patients presenting with severe primary aortic valve disease-specifically chronic pressure overload (severe aortic stenosis) or chronic volume overload (severe aortic regurgitation)-who are scheduled for an elective full-root Ross procedure (pulmonary autograft replacement of the aortic valve). Patients are recruited prospectively and are evaluated without a history of obstructive coronary artery disease, prior myocardial infarction, primary non-ischemic cardiomyopathy, or systemic connective tissue disorders.
설명
Inclusion Criteria:
- Severe primary aortic valve stenosis, regurgitation, or mixed lesion scheduled for an elective Ross procedure.
- Informed written consent to participate in serial prospective imaging.
Exclusion Criteria:
- Documented coronary artery disease (≥ 50% stenosis or previous coronary revascularization).
- Prior myocardial infarction or primary non-ischemic cardiomyopathy.
- Severe renal impairment (estimated Glomerular Filtration Rate < 30 mL/min/1.73 m²).
- Associated congenital heart disease causing volume overload ex: VSD and PDA.
- Systemic connective tissue disorders (Marfan, Loeys-Dietz, or Ehlers-Danlos syndromes).
- Standard contraindications to contrast-enhanced CMR (incompatible ferromagnetic implants, severe claustrophobia).
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: COHORT
- 시간 관점: PROSPECTIVE
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Diffuse myocardial fibrosis
기간: Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
|
Quantify the serial longitudinal changes in diffuse myocardial interstitial fibrosis-measured by indexed extracellular volume (iECV, in mL/m²)-from baseline to 12 months postoperatively in young adults undergoing the Ross procedure. |
Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
|
|
Diffuse myocardial fibrosis
기간: Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
|
Quantify the serial longitudinal changes in diffuse myocardial interstitial fibrosis-measured by extracellular volume fraction (ECV, in %) |
Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Subclinical myocardial mechanical recovery
기간: Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
|
Measured by 3D CMR feature-tracking strain analysis by 3D global longitudinal strain (3D-GLS) |
Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
|
|
Subclinical myocardial mechanical recovery
기간: Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
|
Measured by 3D CMR feature-tracking strain analysis by 3D global circular strain (3D-GCS) |
Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
|
|
Subclinical myocardial mechanical recovery
기간: Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
|
Measured by 3D CMR feature-tracking strain analysis by global radial strain [GRS]. |
Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
|
|
Subclinical myocardial mechanical recovery
기간: Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
|
Measured through 3D CMR feature-tracking strain analysis by peak diastolic strain rate. |
Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- CMR-ROSS
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .